EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Precision Medicine in Epilepsy: Diagnostic Yield by Next-Generation Sequencing and Genotype–Phenotype Findings in a Romanian Cohort

Lăcrămioara Ionela Butnariu iD, Ecaterina Grigore, Thomas Gabriel Schreiner iD, Aurora Băgiag, Setalia Popa iD, Ioana Grigore

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Lăcrămioara Ionela Butnariu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Epilepsy, High-Throughput Nucleotide Sequencing, Genetic Association Studies, Precision Medicine. Die Arbeit nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy ranks among the most prevalent neurological disorders globally, with a substantial proportion of cases, particularly in pediatric populations, attributed to genetic etiologies. This study provides the first molecular characterization of suspected genetic epilepsy in a pediatric cohort from the Moldova region of Romania. Following the exclusion of 124 patients with secondary acquired or structural causes from an initial cohort of 159, we enrolled 35 individuals with a high suspicion of primary genetic epilepsy, who underwent targeted gene panel testing or whole-exome sequencing (WES). Pathogenic (P) or likely pathogenic (LP) variants were identified in 13 patients (37.1%); variants of uncertain significance (VUSs) were identified in another 13 patients (37.1%), comprising 15 distinct VUSs; and negative results were observed in the remaining 9 patients (25.7%). Genes regulating ion channels and synaptic signaling, notably SCN1A, KCNB1, and GNAO1, were predominantly implicated in early-onset, drug-resistant epileptic encephalopathies, whereas structural copy number variations (CNVs) underpinned syndromic phenotypes. We identified one novel pathogenic variant in SCN1A, thereby expanding the known mutational spectrum. Furthermore, in silico predictions and de novo occurrence patterns supported the pathogenicity of several VUSs, underscoring the critical value of familial segregation analyses. Despite the notable diagnostic yield, the high VUS rate underscores the ongoing need for refined variant interpretation criteria and the integration of functional validation data to improve classification accuracy. Collectively, our findings support the clinical utility of next-generation sequencing (NGS) in informing therapeutic decisions, enabling genetic counseling, and improving prognostic accuracy. These results suggest that NGS should be considered early in the diagnostic workup of unexplained or drug-resistant epilepsy, particularly in patients with clinical features suggestive of a genetic etiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyHigh-Throughput Nucleotide SequencingGenetic Association StudiesPrecision MedicineHumansFemaleChildMaleRomaniaChild, PreschoolDNA Copy Number VariationsMutationInfantCohort StudiesPhenotypeAdolescentExome Sequencing

Stichwörter der Autor:innen

Romanian cohortcopy number variationsdevelopmental and epileptic encephalopathygenetic epilepsygenotype–phenotype findingsion channel genesnext-generation sequencingprecision medicinevariants of uncertain significancewhole-exome sequencing

Autor:innen und Institutionen

  • Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Regional Center for Medical Genetics Iasi, Saint Mary's Emergency Children Hospital, 700309 Iasi, Romania.
  • Iuliu Haţieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Neurology, Saint Mary's Emergency Children Hospital, 700309 Iasi, Romania.

ORCID-Profile: Lăcrămioara Ionela Butnariu, Thomas Gabriel Schreiner, Setalia Popa

Zitieren

APA

Butnariu, L. I., Grigore, E., Schreiner, T. G., Băgiag, A., Popa, S., & Grigore, I. (2026). Precision Medicine in Epilepsy: Diagnostic Yield by Next-Generation Sequencing and Genotype–Phenotype Findings in a Romanian Cohort. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198878

Vancouver

Butnariu LI, Grigore E, Schreiner TG, Băgiag A, Popa S, Grigore I. Precision Medicine in Epilepsy: Diagnostic Yield by Next-Generation Sequencing and Genotype–Phenotype Findings in a Romanian Cohort. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198878

BibTeX
@article{Butnariu2026,
  author = {Butnariu, Lăcrămioara Ionela and Grigore, Ecaterina and Schreiner, Thomas Gabriel and Băgiag, Aurora and Popa, Setalia and Grigore, Ioana},
  title = {Precision Medicine in Epilepsy: Diagnostic Yield by Next-Generation Sequencing and Genotype–Phenotype Findings in a Romanian Cohort},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198878}
}
Kostenlos starten →